Physician profile
William Jay Nicholson
NPI 1861435406
$999,777.76
in general payments reported to CMS, 2019-2025
24 companies · $83K in 2025
The $83K reported for 2025 was more than what 98% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $478K · 2020: $58K · 2021: $100K · 2022: $85K · 2023: $114K · 2024: $82K · 2025: $83K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $150K · Consulting Fee: $39K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $39K · Travel and Lodging: $31K · Food and Beverage: $12K · Honoraria: $7,250 · Education: $1.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $150,433.00 |
| Consulting Fee | $39,012.50 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $39,000.00 |
| Travel and Lodging | $31,334.83 |
| Food and Beverage | $11,925.20 |
| Honoraria | $7,250.00 |
| Education | $1.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corindus INC. | $353,965.04 | 2019 | |
| Boston Scientific Corporation | $316,440.52 | 2019-2025 | General - Vascular Access, General - Balloon Catheters, Avvigo Guidance System |
| Shockwave Medical, INC | $102,008.93 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $68,766.42 | 2019-2025 | Hi-Torque Balance, Optis, Dragonfly Opstar |
| Medtronic, INC. | $51,119.84 | 2020-2025 | Symplicity G3, Resolute Onyx, Onyx Frontier |
| Teleflex LLC | $35,267.74 | 2022-2024 | Turnpike, Guideliner, Supercross |
| Abiomed | $17,745.66 | 2019-2025 | Impella |
| Arrow International, INC. | $14,688.85 | 2021-2024 | Manta, Guideliner |
| Asahi Intecc USA, INC. | $14,325.21 | 2019-2025 | Asahi Peripheral Vascular Wires, Asahi Coronary Wires, Asahi Ptca Guide Wire |
| Medtronic Vascular, INC. | $12,103.64 | 2019-2020 | |
| Cordis US Corp. | $8,800.31 | 2025 | |
| Edwards Lifesciences Corporation | $1,723.13 | 2021-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Siemens Medical Solutions USA, INC. | $1,340.33 | 2021-2025 | Artis Icono Floor |
| Avinger INC. | $764.49 | 2019 | |
| Heartflow, INC. | $173.38 | 2019-2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $138.77 | 2019-2020 | |
| Baylis Medical Company INC | $109.32 | 2019 | |
| W. L. Gore & Associates, INC. | $104.67 | 2022-2024 | Gore Cardioform Septal Occluder |
| Seigla Medical, INC. | $91.29 | 2024 | |
| Verge Medical, INC. | $87.53 | 2023 | |
| Cardinal Health 200 LLC | $12.69 | 2019 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Nicholson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.